156 related articles for article (PubMed ID: 9427379)
1. Monoamine metabolite levels in CSF of SIV-infected rhesus monkeys (Macaca mulatta).
Koutsilieri E; Götz ME; Sopper S; Stahl-Hennig C; Czub M; ter Meulen V; Riederer P
Neuroreport; 1997 Dec; 8(17):3833-6. PubMed ID: 9427379
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
Mignot E; Laude D; Elghozi JL
J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
[TBL] [Abstract][Full Text] [Related]
3. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
4. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
[TBL] [Abstract][Full Text] [Related]
5. Monoamine metabolites in the CSF of conscious unrestrained cats.
Degrell I; Zenner K; Kummer P; Stock G
Brain Res; 1983 Oct; 277(2):283-7. PubMed ID: 6196083
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of the effect of different social rearing conditions on cerebrospinal fluid norepinephrine and biogenic amine metabolites in rhesus monkeys.
Kraemer GW; Ebert MH; Schmidt DE; McKinney WT
Neuropsychopharmacology; 1989 Sep; 2(3):175-89. PubMed ID: 2477005
[TBL] [Abstract][Full Text] [Related]
7. CSF monoamine metabolites in chronic pain.
France RD; Urban BJ; Pelton S; Kilts CD; Hong JS; Nemeroff CB
Pain; 1987 Nov; 31(2):189-198. PubMed ID: 2448727
[TBL] [Abstract][Full Text] [Related]
8. Effects of 2,4-dichlorophenoxyacetic acid (2,4-D) on biogenic amines and their acidic metabolites in brain and cerebrospinal fluid of rats.
Elo HA; MacDonald E
Arch Toxicol; 1989; 63(2):127-30. PubMed ID: 2471493
[TBL] [Abstract][Full Text] [Related]
9. Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.
Barkai AI; Kowalik S; Reches A
Psychopharmacology (Berl); 1984; 84(3):352-5. PubMed ID: 6083575
[TBL] [Abstract][Full Text] [Related]
10. Probenecid sensitive pathway of elimination of dopamine and serotonin metabolites in CSF of the rat.
Elghozi JL; Mignot E; Le Quan-Bui KH
J Neural Transm; 1983; 57(1-2):85-94. PubMed ID: 6194256
[TBL] [Abstract][Full Text] [Related]
11. Tryptophan and biogenic amine metabolites in post-mortem human cisternal fluid: effects of post-mortem interval and agonal time.
Kärkelä J; Scheinin M
J Neurol Sci; 1992 Feb; 107(2):239-45. PubMed ID: 1373441
[TBL] [Abstract][Full Text] [Related]
12. Changes in 5-HIAA and 5-HT levels in lumbar CSF following morphine administration to conscious dogs.
Bardon T; Ruckebusch M
Neurosci Lett; 1984 Aug; 49(1-2):147-51. PubMed ID: 6208513
[TBL] [Abstract][Full Text] [Related]
13. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
14. Biogenic amine activity in response to fluoxetine and desipramine in differentially reared rhesus monkeys.
Clarke AS; Ebert MH; Schmidt DE; McKinney WT; Kraemer GW
Biol Psychiatry; 1999 Jul; 46(2):221-8. PubMed ID: 10418697
[TBL] [Abstract][Full Text] [Related]
15. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.
Vaughn DM; Smyth GB; Whitmer WL; Satjawatcharaphong C
Vet Res Commun; 1989; 13(3):237-49. PubMed ID: 2476887
[TBL] [Abstract][Full Text] [Related]
16. Dopamine deficits and regulation of the cAMP second messenger system in brains of simian immunodeficiency virus-infected rhesus monkeys.
Jenuwein M; Scheller C; Neuen-Jacob E; Sopper S; Tatschner T; ter Meulen V; Riederer P; Koutsilieri E
J Neurovirol; 2004 Jun; 10(3):163-70. PubMed ID: 15204921
[TBL] [Abstract][Full Text] [Related]
17. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
Eklundh T; Eriksson M; Sjöberg S; Nordin C
J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical changes in pigeon cerebrospinal fluid during chronic administration of buspirone or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
Nader MA; Barrett JE
Pharmacol Biochem Behav; 1989 Jan; 32(1):227-32. PubMed ID: 2471984
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of chronic developmental lead treatment on biogenic amines and metabolites in monkey cerebrospinal fluid.
Ferguson SA; Kraemer GW; Bowman RE; Schmidt DE; Ebert MH
Neurotoxicol Teratol; 1993; 15(4):229-35. PubMed ID: 8413076
[TBL] [Abstract][Full Text] [Related]
20. Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone.
Garrick NA; Seppala T; Linnoila M; Murphy DL
Psychopharmacology (Berl); 1985; 86(3):265-9. PubMed ID: 2412251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
